Elanco Animal Health Inc (ELAN)
13.04
-0.27
(-2.03%)
USD |
NYSE |
Apr 25, 16:00
13.04
0.00 (0.00%)
Pre-Market: 20:00
Elanco Animal Health Gross Profit Margin (Quarterly): 50.14% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 50.14% |
| September 30, 2023 | 54.40% |
| June 30, 2023 | 58.94% |
| March 31, 2023 | 60.70% |
| December 31, 2022 | 54.52% |
| September 30, 2022 | 54.00% |
| June 30, 2022 | 58.81% |
| March 31, 2022 | 58.48% |
| December 31, 2021 | 54.14% |
| September 30, 2021 | 55.61% |
| June 30, 2021 | 56.92% |
| March 31, 2021 | 54.19% |
| December 31, 2020 | 47.58% |
| Date | Value |
|---|---|
| September 30, 2020 | 50.34% |
| June 30, 2020 | 49.49% |
| March 31, 2020 | 49.39% |
| December 31, 2019 | 47.93% |
| September 30, 2019 | 53.27% |
| June 30, 2019 | 54.45% |
| March 31, 2019 | 52.98% |
| December 31, 2018 | 48.39% |
| September 30, 2018 | 51.41% |
| June 30, 2018 | 43.98% |
| March 31, 2018 | 51.10% |
| December 31, 2017 | 46.31% |
| September 30, 2017 | 46.03% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
47.58%
Minimum
Dec 2020
60.70%
Maximum
Mar 2023
53.86%
Average
54.19%
Median
Mar 2021
Gross Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 73.26% |
| Catalent Inc | 16.70% |
| NanoString Technologies Inc | 36.19% |
| Cytokinetics Inc | -4.98K% |
| Geron Corp | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -17.82% |
| Return on Assets | -8.12% |
| Return on Invested Capital | -9.60% |
| Profit Margin (Quarterly) | -13.62% |
| Operating Margin (Quarterly) | 0.97% |
| Return on Net Operating Assets | -8.76% |